Artemis Therapeutics Inc (OTCQB:ATMS)

0.8497
Delayed Data
As of Apr 23
 0.00 / 0.00%
Today’s Change
0.65
Today|||52-Week Range
1.70
-46.89%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues244.0K0.000.000.00
 
 
Cost of Goods Sold36.0K0.000.000.00
 
 
Depreciation And Amortization4.0K0.000.000.00
 
 
 
Operating ExpensesGross Income204.0K0.000.000.00
 
 
General Expenses554.0K164.0K255.0K1.0M
 
 
 
 
 
Research And Development48.0K0.0089.0K309.0K
 
 
 
 
Total Operating Expenses594.0K164.0K255.0K1.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-350.0K-164.0K-255.0K-1.0M
 
 
 
 
 
Extraordinary Credit--35.0K0.000.00
 
 
Interest Expense On Debt7.0K3.0K0.000.00
 
 
 
Other Expenses719.0K-7.0K-9.0K-104.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income362.0K-139.0K-264.0K-1.1M
 
 
 
 
 
Net Income362.0K-139.0K-264.0K-972.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS863.5K863.5K5.0M4.9M
 
 
 
 
 
Shares To Calculate EPS Diluted863.5K863.5K5.0M4.9M
 
 
 
 
 
 
Earnings Per ShareEPS$0.50$0.00-$0.05-$0.20
 
 
 
 
EPS Diluted$0.50-$0.16-$0.05-$0.20